- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: allosteric inhibitor of BCR-ABL1
Total 430033 results
-
Imperial College LondonNovartis PharmaceuticalsCompletedChronic Myeloid Leukemia | Newly DiagnosedUnited Kingdom
-
Ariad PharmaceuticalsTerminatedChronic Myeloid LeukemiaUnited States, Australia, Austria, Belgium, Canada, Czech Republic, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Singapore, Slovakia, Spain, Sweden, Switz... and more
-
University of BolognaNovartisCompleted
-
Ascentage Pharma Group Inc.HealthQuest Pharma Inc.Active, not recruitingChronic Myeloid Leukemia, Chronic PhaseChina
-
Norwegian University of Science and TechnologyCompletedLeukemia, Myeloid, Chronic-PhaseSweden, Finland, Norway
-
Hikma Pharmaceuticals LLCCompletedChronic Myeloid Leukemia, Chronic PhaseJordan
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Singapore General HospitalCompletedChronic Myeloid LeukemiaSingapore
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia (CML)
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
CTI BioPharmaNational Cancer Institute (NCI)TerminatedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Milton S. Hershey Medical CenterTerminatedChronic Myeloid Leukemia, Chronic PhaseUnited States
-
Gesellschaft fur Medizinische Innovation - Hamatologie...Crolll GmbhCompletedChronic Myelogenous Leukemia (CML)Germany
-
Ariad PharmaceuticalsCompletedChronic Myelogenous Leukemia | Hematologic MalignanciesUnited States
-
Loyola UniversityNational Cancer Institute (NCI)Completed
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaJapan
-
Norwegian University of Science and TechnologyCompletedChronic Myeloid LeukemiaSweden, Finland, Norway
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaChina
-
Università degli Studi di BresciaCompleted
-
Seoul St. Mary's HospitalMinistry of Health & Welfare, KoreaUnknownChronic Myeloid Leukemia | Imatinib | Complete Molecular ResponseKorea, Republic of
-
European Society for Blood and Marrow TransplantationBristol-Myers SquibbTerminatedChronic Myeloid LeukemiaSwitzerland, United Kingdom, France, Germany
-
Bristol-Myers SquibbTerminated
-
Uppsala UniversityKarolinska University Hospital; Uppsala University HospitalCompletedHealth Care Quality | Health Care EvaluationSweden
-
Hospital Universitario Dr. Jose E. GonzalezFernando De la Garza SalazarRecruitingChronic Myeloid Leukemia, Chronic PhaseMexico
-
Affiliated Hospital of Nantong UniversityRecruitingCML | Treatment-free Remission | FolateChina
-
Poitiers University HospitalCompletedChronic Phase of Chronic Myeloid Leukemia
-
M.D. Anderson Cancer CenterWyeth is now a wholly owned subsidiary of PfizerCompletedLeukemia | Chronic Myeloid Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Centre Hospitalier Universitaire de NīmesRecruitingLeukemia | Chronic Leukemia | Myelogenous Leukemia | BCR-ABL Positive Acute Myeloid LeukemiaFrance
-
Novartis PharmaceuticalsTerminatedPhilidelphia Positive Chronic Myeloid LeukaemiaAustralia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Celgene CorporationCompletedAzacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)Leukemia | Stem Cell TransplantationUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Shenzhen Second People's HospitalHainan General Hospital; Sanya Central Hospital; First Affiliated Hospital of... and other collaboratorsRecruitingChronic Myeloid Leukemia, Chronic Phase | Flumatinib | ImatinibChina
-
The University of Hong KongUnknownCessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous LeukaemiaLeukemia, Myelogenous, Chronic PhaseHong Kong
-
M.D. Anderson Cancer CenterCompleted
-
Kanto CML Study GroupUnknownMyelogenous Leukemia, Chronic, Chronic PhaseJapan
-
Shenzhen Second People's HospitalRecruitingChronic Myeloid Leukemia in Chronic PhaseChina
-
Novartis PharmaceuticalsTerminatedChronic Myeloid Leukemia in Chronic PhaseBelgium, Germany
-
University of JenaNovartis Pharmaceuticals; Ludwig-Maximilians - University of MunichActive, not recruiting
-
University of Sao Paulo General HospitalUnknownLeukemia, Myeloid, Chronic-PhaseBrazil
-
Hospices Civils de LyonUnknown
-
Novartis PharmaceuticalsCompletedPhiladelphia Positive (Ph+) Chronic Myelogenous LeukemiaUnited States, France, Korea, Republic of, Thailand, Italy, Netherlands, Turkey, Hungary, Russian Federation, Spain, United Kingdom, Japan, Malaysia
-
Il-Yang Pharm. Co., Ltd.CompletedBone Marrow Diseases | Hematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Philadelphia ChromosomeKorea, Republic of, Indonesia, Thailand, Philippines
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaUnited States, United Kingdom, Hungary, Japan, Saudi Arabia, Australia, Germany, Canada, France, Netherlands, Spain, Lebanon, Turkey, Korea, Republic of, Argentina, Brazil, Bulgaria, Czechia, Israel, Italy, Mexico, Romania, Russian... and more
-
Novartis PharmaceuticalsCompletedChronic Myeloid Leukemia (CML)Korea, Republic of
-
Ariad PharmaceuticalsTerminatedChronic Phase Chronic Myeloid LeukemiaBelgium
-
Emory UniversityTerminatedLeukemia | Chronic Myeloid Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Bristol-Myers SquibbCompletedChronic Phase Chronic Myeloid LeukemiaFrance, Italy, United States, Korea, Republic of, Germany
-
University of Michigan Rogel Cancer CenterNovartisWithdrawnChronic Myeloid LeukemiaUnited States